ClinicalTrials.gg
CompletedNCT07770321Updated Aug 18, 2026

Effect of Audio-analgesia Using Binaural Beats and Instrumental Music on the Behaviour of Minimally Sedated Pediatric Patients

An interventional study of Audio analgesia and 0.3 mg/kg midazolam in Behavior Management, sponsored by Rania Ahmedien. Completed at 1 site in Egypt. Open to participants aged 5 Years to 9 Years. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Rania Ahmedien · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Oct 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
5 Years to 9 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the effect of audio analgesia (using binaural beats and instrumental music) in conjunction with a minimal dose of intranasal aerosolized midazolam on acquiring satisfactory patient cooperation.

02

Conditions studied

  • Behavior Management

Browse trials for

03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 36 is below the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

This is the only study on the registry with Rania Ahmedien as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Frankl scale score 1 or 2 (Definitely Negative or Negative behavior)
  • I, II physical status (ASA I, II)
  • Patient presenting with at least one primary molar indicated for extraction.
  • Parent/guardian written consent.

Exclusion criteria

Exclusion Criteria:

  • Medically compromised patients.
  • Cognitively impaired patients.
  • Hearing disabilities.
  • Mouth breathers.
  • to local anesthetic drugs used.
  • Patients with known allergy to midazolam.
  • Teeth with ankylosed roots
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    0.3 mg/kg aerosolized midazolam + audio analgesia

    Other: Audio analgesia · Drug: 0.3 mg/kg midazolam

  • Experimental
    0.3 mg/kg aerosolized midazolam

    Drug: 0.3 mg/kg midazolam

  • Active comparator
    0.5 mg/kg aerosolized midazolam

    Drug: 0.5 mg/kg midazolam

Interventions

  • OtherAudio analgesia

    Patients received a procedural sedation session using audio analgesia using binaural beats and instrumental music

  • Drug0.3 mg/kg midazolam

    Patients received a procedural sedation session, using aerosolized solution of 0.3 mg/kg Midazolam

  • Drug0.5 mg/kg midazolam

    Patients received a procedural sedation session, using aerosolized solution of 0.5 mg/kg Midazolam

06

What researchers measure

Primary outcomes

  1. Ease of treatment completion

    The ease of treatment completion was measured using a five point scale (1-5) with higher scores indicating easier treatment

    Time frame: throughout the procedure completion

  2. Child's dental anxiety

    It was assessed using Venham's Clinical Anxiety Scale with scores ranging 0 (best) to 5 (worst)

    Time frame: throughout the procedure completion

Secondary outcomes

  1. Analgesic effect

    It was assessed using the FLACC scale. The scale is scored in a range of 0-10 with 0 representing no pain.

    Time frame: throughout the procedure completion

  2. Sedation Depth

    The sedation depth was assessed by the Richmond Agitation Sedation Scale with scores ranging from -5 to +4, with lower scores indicating deeper sedation

    Time frame: throughout the procedure completion

  3. Parental satisfaction

    The parents/guardians will be asked to rate their overall satisfaction with care under sedation by using a simple image of 5 point Likert scale with higher scores indicating greater satisfaction

    Time frame: throughout the procedure completion

  4. Oxygen saturation

    Time frame: From enrollment and throughout procedure completion

  5. Heart rate

    Time frame: From enrollment and throughout procedure completion

  6. Blood pressure

    Time frame: From enrollment and throughout procedure completion

07

Study locations

1 site
  • Faculty of Dentistry, Alexandria University, Egypt
    Alexandria, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07770321
Lead sponsor
Rania Ahmedien
Responsible party
Rania Ahmedien (MSc Candidate in Pediatric Dentistry, Alexandria University) — Sponsor-investigator
First posted
Aug 18, 2026
Start date
Oct 12, 2025
Primary completion
Apr 6, 2026
Completion
Apr 6, 2026
Last update
Aug 18, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion